Male Breast Cancer: Understanding the Biology for Improved Patient Care
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Fatima Cardoso, MD
Champalimaud Cancer Center (Portugal)
Study Chair - Sharon H. Giordano, MD, MPH
M. D. Anderson Cancer Center (TX, USA)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
93 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Zna Middelheim
Antwerp, Belgium
- Chu St Pierre
Brussels, Belgium
- Cliniques Universitaires Saint-Luc
Brussels, Belgium
- Cliniques Universitaires St. Luc
Brussels, Belgium
- Hopital Universitaire Brugmann
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- Universitair Ziekenhuis Antwerpen
Edegem, Belgium
- Hopital de Jolimont
Haine-Saint-Paul, Belgium
- Uz Leuven
Leuven, Belgium
- Zna Jan Palfijn
Merksem, Belgium
- Chu Ucl Namu - Clinique Sainte Elisabeth
Namur, Belgium
- Az Damiaan - Campus Sint-Jozef
Ostend, Belgium
- Centro Regional Integrado de Oncologia
Fortaleza, Brazil
- Centro de Pesquisas Clinicas Em Oncologia
Porto Alegre, Brazil
- Ain Shams University Hospital
Cairo, Egypt
- Alexandra Hospital
Athens, Greece
- Aretaieio Hospital
Athens, Greece
- General Hospital of Air Force
Athens, Greece
- Hippokration General Hospital of Athens
Athens, Greece
- Hygeia Hospital
Athens, Greece
- Iaso General Hospital
Athens, Greece
- University General Hospital Heraklion
Heraklion, Greece
- Agioi Anargiroi Hospital
Kifissia, Greece
- General University Hospital Papageorgiou
Thessaloniki, Greece
- Thermi Clinic
Thessaloniki, Greece
- Cork University Hospital
Cork, Ireland
- Beaumont Hospital
Dublin, Ireland
- Mater Misericordia Hospital
Dublin, Ireland
- St. James'S Hospital
Dublin, Ireland
- St. Vincent'S Hospital
Dublin, Ireland
- Waterford Regional Hospital
Waterford, Ireland
- Instituto Nacional de Cancerologia
México, Mexico
- Boog
Amsterdam, Netherlands
- Instituto de Enfermedades Neoplasicas
Lima, Peru
- Medical University of Gdansk
Gdansk, Poland
- Maria Sklodowska-Curie Memorial Cancer Centre
Warsaw, Poland
- Champalimaud Cancer Center
Lisbon, Portugal
- Instituto Portugues de Oncologia - Centro Do Porto
Porto, Portugal
- Institute of Oncology and Radiology
Belgrade, Serbia
- Hospital General Vall D'Hebron
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 12 May 2026
- Registered enrollment
- 200
- Registry id
- NCT01101425
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.